AIG
DOVA

American International Group’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

American International Group’s Portfolio DOVA Stock Details DOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-5,259
Closed -$147K – 3097
2019
Q3 		$147K Buy
5,259
+67
+1% +$1.09K ﹤0.01% 2375
2019
Q2 		$73K Sell
5,192
-2,320
-31% -$22.1K ﹤0.01% 2837
2019
Q1 		$67K Sell
7,512
-244
-3% -$1.98K ﹤0.01% 2782
2018
Q4 		$59K Sell
7,756
-59
-0.8% -$950 ﹤0.01% 2829
2018
Q3 		$164K Buy
7,815
+140
+2% +$3.33K ﹤0.01% 2553
2018
Q2 		$230K Buy
7,675
+3,681
+92% +$100K ﹤0.01% 2273
2018
Q1 		$108K Buy
3,994
+538
+16% +$16.1K ﹤0.01% 2622
2017
Q4 		$100K Buy
3,456
+64
+2% +$1.75K ﹤0.01% 2735
2017
Q3 		$82K Buy
+3,392
New +$80.4K ﹤0.01% 2723

American International Group's DOVA Position: Q4 2019 in Review

American International Group sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 5,259 shares — an estimated $147K sold.

American International Group first reported a position in DOVA in Q3 2017 and held it in 9 quarters. The position peaked at $230K in Q2 2018. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

  • American International Group reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • American International Group sold 5,259 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $147K.
  • American International Group first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 9 quarters.
  • American International Group's Dova Pharmaceuticals, Inc. Common Stock position peaked at $230K in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on American International Group's 13F filing for Q4 2019, filed 5 Feb 2020.